Screener
Capricor Therapeutics CAPR Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| Line item | March 31, 2026 / (unaudited) | December 31, 2025 | December 31, 2025 |
|---|---|---|---|
| CURRENT LIABILITIES | |||
| Accounts payable | $3,927,941 | $ | $1,654,754 |
| Accrued expenses | 10,528,351 | 15,557,646 | |
| Lease liabilities, current | 841,135 | 202,376 | |
| CIRM liability, current | 6,339,862 | 6,421,984 | |
| Deferred revenue, current | 12,000,000 | 12,000,000 | |
| TOTAL CURRENT LIABILITIES | 33,637,289 | 35,836,760 | |
| LONG-TERM LIABILITIES |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's operating lease liabilities (current)?
- Capricor Therapeutics (CAPR) reported operating lease liabilities (current) of $841.14K in Q1 2026.
- How has Capricor Therapeutics's operating lease liabilities (current) changed year-over-year?
- Capricor Therapeutics's operating lease liabilities (current) decreased by 0.1% year-over-year, from $842.1K to $841.14K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Capricor Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude